BridgeMD
New treatment option for Healthy Volunteer
Official title A Study to Evaluate How the Study Drug Moves Through the Body, Adverse Events, and How the Body Tolerates ABBV-547 Injections
ClinicalTrials.gov ID: NCT07232004
What this study is testing
What is ABBV-547?
ABBV-547 is an investigational medicine, being studied as a potential treatment for healthy volunteer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to assess how safe, effective, and tolerable ABBV-547 is in adult participants in the United States and Japan. There will be 2 parts to this study.
- Phase 1: an early, usually small safety study
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55. Healthy volunteers may be eligible.
You may be able to join if
- A condition of general good health, based upon the results of a medical history, physical examination, vital signs, laboratory profile and a 12-lead...
- Part 1: BMI is \>= 18.0 to \<= 29.9 kg/m\^2 after rounding to the tenths decimal at Screening. BMI is calculated as weight in kg divided by the...
- Part 2: must have discontinued use of phototherapy (e.g., UVA or UVB) at least 2 weeks prior to the baseline visit (Day 1) and PUVA phototherapy at...
You likely can't join if
- History of any clinically significant sensitivity or allergy to any medication or food.
- Part 2: uses any herbal supplements within the 2-week period prior to study treatment administration.
- Part 2: received any biologics including investigational agents within 2.5 half-lives prior to Baseline.
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, Alabama, United States
- Bryant, Arkansas, United States
- Anaheim, California, United States
- Los Angeles, California, United States
- Sacramento, California, United States
- Boca Raton, Florida, United States
- Miami Lakes, Florida, United States
- Tampa, Florida, United States
- Darien, Illinois, United States
- Grayslake, Illinois, United States
- Boston, Massachusetts, United States
- New Brighton, Minnesota, United States
- Saint Joseph, Missouri, United States
- Omaha, Nebraska, United States
- New City, New York, United States
- The Bronx, New York, United States
- Portland, Oregon, United States
- Rapid City, South Dakota, United States
- Houston, Texas, United States
- Pflugerville, Texas, United States
+ 2 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, Alabama, United States; Bryant, Arkansas, United States; Anaheim, California, United States; Los Angeles, California, United States; Sacramento, California, United States; Boca Raton, Florida, United States and 16 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.